FRACTYL HEALTH INC (GUTS) Stock News

USA - NASDAQ:GUTS - US35168W1036 - Common Stock

1.125 USD

+0.02 (+2.27%)

Last: 11/10/2025, 3:07:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

GUTS Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Fractyl Health, Inc.

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

5 days ago - By: Fractyl Health, Inc.

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

2 months ago - By: Stocktwits - Mentions: IWC VXF

News Image

GUTS Stock Rallied About 28% Today – Here’s Why

3 months ago - By: The Motley Fool

Fractyl Health Posts 62% Wider Q2 Loss

3 months ago - By: Benzinga

An Overview of Fractyl Health's Earnings

a month ago - By: Fractyl Health, Inc.

Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity

a month ago - By: Fractyl Health, Inc.

Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity

2 months ago - By: Benzinga - Mentions: SNGX CASI SSKN CRNX ...

12 Health Care Stocks Moving In Friday's Intraday Session

2 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

2 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

2 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

2 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

2 months ago - By: Fractyl Health, Inc.

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

2 months ago - By: Fractyl Health, Inc.

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

3 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates

3 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates

3 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

3 months ago - By: Fractyl Health, Inc.

Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference

3 months ago - By: Fractyl Health, Inc.

Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference

3 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering

3 months ago - By: Fractyl Health, Inc.

Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering